The influence of migraine and female hormones on capsaicin-induced dermal blood flow

Frovatriptan 2.5 mg plus dexketoprofen (25 mg or 37.5 mg) in menstrually related migraine. Subanalysis from a double-blind, randomized trial

(2014) G Allais et al.   CEPHALALGIA

Development of an experimental model to study trigeminal nerve-mediated vasodilation on the human forehead

(2014) K Ibrahimi et al.   CEPHALALGIA

Reduced trigeminovascular cyclicity in patients with menstrually related migraine

(2014) K. Ibrahimi et al.   NEUROLOGY

Sex Differences in the Prevalence, Symptoms, and Associated Features of Migraine, Probable Migraine and Other Severe Headache: Results of the American Migraine Prevalence and Prevention (AMPP) Study

(2013) Dawn C. Buse et al.   HEADACHE

Is the migrainous female brain different? Some new evidence

(2012) V. Guidetti et al.   BRAIN

Current Topics and Controversies in Menstrual Migraine

(2012) Anne H. Calhoun   HEADACHE

Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010

(2012) Theo Vos et al.   LANCET

Randomized controlled trial of the CGRP receptor antagonist MK-3207 in the acute treatment of migraine

(2011) David J Hewitt et al.   CEPHALALGIA

Mechanisms of Pain Modulation by Sex Hormones in Migraine

(2011) Saurabh Gupta et al.   HEADACHE

Sex hormone receptor gene polymorphisms and migraine: A systematic review and meta-analysis

(2010) Markus Schürks et al.   CEPHALALGIA

Postpartum headache

(2010) A.M. Klein et al.   INTERNATIONAL JOURNAL OF OBSTETRIC ANESTHESIA

Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974)

(2009) Simon R. Sinclair et al.   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

EstrogenGrowth Factor Interactions and Their Contributions to Neurological Disorders

(2008) Helen E. Scharfman et al.   HEADACHE

Calcitonin Gene-Related Peptide8-37 Antagonizes Capsaicin-Induced Vasodilation in the Skin: Evaluation of a Human in Vivo Pharmacodynamic Model

(2008) B. J. Van der Schueren et al.   JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS

Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial

(2008) Tony W Ho et al.   LANCET

Vascular Actions of Estrogens: Functional Implications

(2008) V. M. Miller et al.   PHARMACOLOGICAL REVIEWS